Knowledge Hub

Tracking financial flows for immunization in Honduras

Authors:

Werner Valdés et al.

Vaccine effectiveness of PCV13 in a 3 + 1 vaccination schedule

Authors:

Raphael Weinberger et al.

Service delivery Germany Pneumococcal disease

Pneumococcal AMC outcomes and impact evaluation

Authors:

Gavi, the Vaccine Alliance

Global initiatives Pneumococcal disease

Progress in introduction of pneumococcal conjugate vaccine — worldwide, 2000–2012

Authors:

Centers for Disease Control and Prevention (CDC)

Vaccines & delivery devices Pneumococcal disease

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants

Authors:

Judith Spijkerman et al.

Service delivery Netherlands Kingdom of the Pneumococcal disease

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: A pooled analysis of multiple surveillance sites

Authors:

Daniel R. Feikin

Service delivery Pneumococcal disease

13-Valent pneumo vaccine (PCV13) in children partially immunized with 7-valent pneumo vaccine

Authors:

Sven Arne Silfverdal et al.

Vaccines & delivery devices Sweden Pneumococcal disease

Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention.

Authors:

Service delivery Italy Pneumococcal disease

Acute exercise enhancement of pneumococcal vaccination response

Authors:

Kate M. Edwards et al.

Service delivery Pneumococcal disease

Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness

Authors:

Lee M. Hampton et al.

Service delivery United States of America Pneumococcal disease

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in Gambia

Authors:

Service delivery Gambia Pneumococcal disease

Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance

Authors:

Service delivery Brazil Pneumococcal disease

Optimizing the use of pneumococcal conjugate vaccine globally

Authors:

Katherine L. O'Brien

Service delivery Pneumococcal disease

Economic impact of pneumococcal protein-D conjugate vaccine (PHiD-CV) on the Malaysian National Immunization Programme

Authors:

Service delivery Malaysia Pneumococcal disease HIB

Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine

Authors:

Service delivery United States of America Pneumococcal disease

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

Authors:

Vaccines & delivery devices Denmark Pneumococcal disease

Pneumonia & Diarrhea Progress Report

Authors:

Global initiatives Pneumococcal disease

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012

Authors:

Service delivery France Pneumococcal disease

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

Authors:

Service delivery United Kingdom Of Great Britain And Northern Ireland Pneumococcal disease

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment

Authors:

Programme management Pneumococcal disease

Knowledge Hub

Tracking financial flows for immunization in Honduras

Vaccine effectiveness of PCV13 in a 3 + 1 vaccination schedule

Pneumococcal AMC outcomes and impact evaluation

Progress in introduction of pneumococcal conjugate vaccine — worldwide, 2000–2012

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: A pooled analysis of multiple surveillance sites

13-Valent pneumo vaccine (PCV13) in children partially immunized with 7-valent pneumo vaccine

Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention.

Acute exercise enhancement of pneumococcal vaccination response

Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in Gambia

Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance

Optimizing the use of pneumococcal conjugate vaccine globally

Economic impact of pneumococcal protein-D conjugate vaccine (PHiD-CV) on the Malaysian National Immunization Programme

Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

Pneumonia & Diarrhea Progress Report

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment

Filters

About

Knowledge Hub

Community

More